Re-irradiation with concurrent chemotherapy is a modality to be considered in select patients with recurrent head and neck cancer. These results should help to better inform both patients and clinicians when considering this treatment.
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine. This record was last updated on 07/03/2016 and may not reflect the most current and accurate biomedical/scientific data available from NLM. The corresponding record at NLM can be accessed at https://www.ncbi.nlm.nih.gov/pubmed/18983342